Analysis of Polymerase Chain Reaction Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
The global polymerase chain reaction market size is expected to attain a valuation of US$ 6.2 billion in 2024. Projected to expand at a CAGR of 10%, worldwide sales of polymerase chain reaction products are foreseen to reach US$ 16 billion by 2034.
The dreadful impact of SARS-CoV-2 surged the need for reliable and rapid detection systems such as quantitative polymerase chain reaction (qPCR). It is the gold standard for detecting the novel coronavirus, owing to its higher specificity and sensitivity than other tests.
Mounting prevalence of chronic and infectious diseases is leading to the increasing application of polymerase chain reaction (PCR) solutions. Technological advancements and substantial investments in pharmaceutical and healthcare industries are pushing polymerase chain reaction market growth toward a more positive trajectory.
Developing economies are expected to offer substantial growth opportunities for PCR product suppliers, led by the intensifying incidence of infectious and chronic diseases, along with soaring R&D initiatives to develop innovative genomic techniques such as PCR. Also, market growth is set to be reinforced by the expansion of healthcare infrastructure across regions, upsurge in healthcare expenditure, and reducing procedural costs for qPCR-based and dPCR-based disease diagnosis in several countries.
Developing economies are beholding rapid modernization and expansion of healthcare facilities. This factor is contributing to the growing demand for clinical diagnostic procedures among diagnostic laboratories, which is resulting in the rising sales of clinical PCR products. Consequently, a surge in pharmaceutical R&D budgets by governments and private organizations is also expected to boost the development of advanced rapid medical diagnostic kits such as real-time polymerase chain reaction (RT-PCR) molecular diagnostics.
Development of RT-qPCR kits that can detect SARS-CoV-2, coupled with their wide acceptance globally to detect corona variants, is mainly driving their sales growth.
| Report Attribute | Detail |
|---|---|
| Polymerase Chain Reaction Market Size (2024E) | US$ 6.2 Billion |
| Forecasted Market Value (2034F) | US$ 16 Billion |
| Global Market Growth Rate (2024 to 2034) | 10% CAGR |
| Japan Market Value (2034F) | US$ 1.1 Billion |
| RT-PCR System Demand Growth (2024 to 2034) | 10.7% CAGR |
| Digital PCR System Sales (2034F) | US$ 2.6 Billion |
| PCR Reagent Sales (2024E) | US$ 1.1 Billion |
| Key Companies Profiled | Bio-Rad Laboratories Inc.; Stilla; Standard BioTools; Siemens Healthineers; BioMerieux S.A; Danaher Corporation; Thermo Fisher Scientific Inc.; Qiagen N.V; Becton Dickinson & Company (BD); Abbott Laboratories; Agilent Technologies; F. Hoffmann-La Roche Ltd.; Microsynth AG. |
“Efficiency of PCR Analysis Increasing its Importance in Diagnostic Field”
PCR technology sales growth is primarily being driven by the rising incidence of target diseases and genetic disorders, continuous technological advancements in PCR diagnostic systems, development of miniaturized portable instruments, and incorporation of robotics, increasing use of biomarker profiling for disease diagnostics, and grants for research activities,
Demand for genomic analysis techniques is gaining traction on the back of microbial identification and detection of genetic mutation’s increasing use in the diagnosis of major infectious diseases such as tuberculosis, HIV, malaria, hepatitis, Staph-related diseases, and genetic disorders such as cancer and fragile X syndrome. Additionally, with the proven efficacy of PCR analysis in the diagnosis and estimation of disease-causing microbes, demand for clinical diagnostic tests including qPCR and dPCR analysis is set to increase at a high pace.
“High Cost of Advanced PCR Technologies”
High cost associated with advanced polymerase chain reaction technologies such as qPCR and digital PCR is acting as a deterrent to their adoption. Current costs associated with qPCR devices are on the higher side. The price of an advanced PCR detection system ranges from US$ 4,000 to US$ 13,000 or more depending on add-on features. Digital PCR instruments are more expensive than RT-PCR systems. As such, these high costs of advanced PCR technologies are limiting their use, especially in developing economies.
“Advanced Diagnostic Solutions through Extensive R&D Investments”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 700 Million |
| Growth Rate (2024 to 2034) | 10.5% CAGR |
| Projected Value (2034F) | US$ 1.8 Billion |
The United States is foreseen to remain the kingpin and account for 45.6% of the North American polymerase chain reaction market share by 2034. Demand for PCR systems is being driven by the presence of advanced healthcare infrastructure and increasing penetration of cutting-edge diagnostic technologies, including PCR systems for research and clinical applications. The adoption of novel biotechnologies, rising awareness about PCR products, and significant fund allocation for research in national budgets are key factors driving market growth in the United States.
“Japan Emerging Market for PCR Technologies in East Asia”
| Attribute | Japan |
|---|---|
| Market Value (2024E) | US$ 400 Million |
| Growth Rate (2024 to 2034) | 10.5% CAGR |
| Projected Value (2034F) | US$ 1.1 Billion |
Growing awareness among physicians and healthcare professionals about the benefits of gene-based disease diagnosis and treatment is increasing the importance of PCR systems in Japan. Moreover, growing public-private support to develop novel PCR technologies is set to account for a particularly high growth rate for the market in the country.
“Investments in R&D for Genetic Engineering”
| Attribute | Pharmaceutical and Biotechnology Industries |
|---|---|
| Segment Value (2024E) | US$ 2.2 Billion |
| Growth Rate (2024 to 2034) | 10.2% CAGR |
| Projected Value (2034F) | US$ 5.7 Billion |
Pharmaceutical and biotechnology companies are poised to capture a big chunk of the global market share by 2034-end. Snowballing test volumes and laboratory automation are projected to increase the demand for PCR services in the pharmaceutical and biotechnology industries.
Gigantic strides made in the domain of pharmacogenomics and the rising trend of self-diagnosis of ailments are expected to push PCR kit sales. Burgeoning investments in R&D of genetic engineering and competition in the discovery of new drugs for diseases such as HIV-AIDS and cancer are also set to increase the use of PCR technologies in pharma and biotech institutions.
Clinical diagnostic labs and hospitals are also making high use of PCR technologies. RT-PCR systems are aiding healthcare specialists in carrying out quick diagnoses and make effective treatment decisions.
“Need for Improved PCR Reagents for Quick Diagnosis”
| Attribute | PCR Reagents |
|---|---|
| Segment Value (2024E) | US$ 1.1 Billion |
| Growth Rate (2024 to 2034) | 10.6% CAGR |
| Projected Value (2034F) | US$ 2.9 Billion |
Continuously increasing number of diagnostic tests and the launch of new reagents specific to the test type are set to augment the demand for reagents used in polymerase chain reactions. Increasing importance of molecular and point-of-care diagnostics will result in higher reliance on PCR reagents.
PCR instruments are also set to exhibit high demand growth over the coming years. Increasing risk of contagious diseases, with many leading to fatalities, is driving the demand for advanced PCR instruments in healthcare facilities.
Key players in the polymerase chain reaction market are embracing innovative approaches such as technological advancements, mergers, and acquisitions to expand their footprint.
Fact.MR provides detailed information about the price points of key producers of polymerase chain reaction products across the world, sales growth, production capacity, and speculative technological expansion, in the recently updated market report.
How big is the polymerase chain reaction market?
The global polymerase chain reaction market is approximated at US$ 6.2 billion in 2024.
How much will the PCR industry be worth by 2034?
The market for polymerase chain reaction products is calculated to reach US$ 16 billion by 2034.
What is the estimated CAGR for the global market?
Demand for PCR products is foreseen to rise at a CAGR of 10% during the study period (2024 to 2034).
Which region is expected to exhibit high demand for polymerase chain reaction technologies?
Sales of polymerase chain reaction systems in North America are forecasted to reach US$ 3.9 billion by 2034.
What are the sales projections for polymerase chain reaction instruments?
Revenue from polymerase chain reaction instruments is evaluated at US$ 1.1 billion in 2024.
How much share Japan is anticipated to hold in the East Asia market?
Japan is estimated to account for 28.9% of the East Asia market share in 2024.
Who are the leading producers of polymerase chain reaction products?
Some of the leading market players are Siemens Healthineers, BioMerieux S.A, Danaher Corporation, Thermo Fisher Scientific Inc., and Qiagen N.V.
Polymerase Chain Reaction Market